Oral Abstract Session:
167. Late Breaker Oral Abstracts: Emerging Infections
Friday, October 5, 2018: 2:00 PM-3:15 PM
Room: S 152-154

Tracks: Transplant ID, Pediatric ID, Trainee, Investigative ID, Global ID, HIV-STD-TB, Epidemiology and Infection Control, Adult ID


Moderators:  D. Vugia, MD, MPH, CA Dept Public Health and Gail Bolan, MD, Centers for Disease Control and Prevention

Presentations:
2:00 PM
LB7
Contract Tracing Investigation Following First Case of Andes Virus in the United States
Aaron Kofman, MD; Paula Eggers, RN; Anne Kjemtrup, DVM, MPVM, PhD; Rebecca Hall, MPH; Shelley Brown, BS; Mary Choi, MD, MPH; Hayley Yaglom, MPH; Monique Duwell, MD, MPH; Barbara Knust, DVM, MPH, DACVPM; John Klena, PhD; Francisco Alvarado-Ramy, MD; Trevor Shoemaker, MPH; Jonathan Towner, PhD; Stuart Nichol, PhD
2:10 PM
LB8
Outbreak of Enterovirus A71 Neurologic Disease in Children — Colorado, 2018
Kevin Messacar, MD; Alexis Burakoff, MD, MPH; William A. Nix, BS; Shannon Rogers, MS; Adriana S. Lopez, MHS; M Steve Oberste, PhD; Susan I. Gerber, MD; Emily Spence-Davizon, MPH; Rachel Herlihy, MD MPH; Samuel Dominguez, MD, PhD
2:20 PM
LB9
Rising High Rate of Invasive Group A Streptococcus Infections Among Persons Experiencing Homelessness in San Francisco, 2010–2017
Tara Scheuer, MPH; Tanya Libby, MPH; Chris Van Beneden, MD, MPH; James Watt, MD, MPH; Arthur Reingold, MD; Mirasol Apostol, MPH; Duc Vugia, MD, MPH
2:30 PM
Changing Epidemiology of Hepatitis A Virus Infections–– United States, 2007─2017
Monique Foster, MD, MPH; Megan Hofmeister, MD, MS, MPH; Shaoman Yin, PhD, MSPH; Paul Weidle, PharmD MPH
2:40 PM
Rapid Rise in Decreased Susceptibility to Azithromycin among Shigella Isolates in the United States: A Look at National Surveillance Data, 2011–2017
Cindy Friedman, MD; Ian Plumb, MRCP MSc; Jared Reynolds, MPH; Jessica Chen, PhD; Kaitlin Tagg, PhD; Hayat Caidi, PhD; Louise Francois Watkins, MD, MPH; Beth Karp, DVM, MPH, DACVPM
2:50 PM
Safety and Efficacy of Fidaxomicin and Vancomycin in Pediatric Patients with Clostridium difficile Infection: Phase III, Multicenter, Investigator-blind, Randomized, Parallel Group (SUNSHINE) Study
Joshua Wolf, MBBS FRACP; Krisztina Kalocsai, MD; Claudia Fortuny, MD, PhD; Stefan Lazar, MD, PhD; Samantha Bosis, MD; Bartosz Korczowski, MD, PhD; Arnaud Petit, MD, PhD; Daniel Bradford, MA, MBBS, DCPSA, PGDPM; Elodie Incera, MSc; Joost Melis, MSc; Rob Van Maanen, MD, FFPM
3:00 PM
Candida auris in NYC: A Health System's Experience Treating the Emerging Drug-Resistant Yeast
Dana Mazo, MD, MSc; Lindsey Gottlieb, MD; Sarah Schaefer, MD; Kinta Alexander, DrPh, MS, MPH, CIC; Jordan Ehni, MPH, CIC; Waleed Javaid, MD; Gopi Patel, MD, MS; Judith Aberg, MD; Scott Lorin, MD, MBA

CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.